 Connection
Jason Gibbons to Buprenorphine
This is a "connection" page, showing publications Jason Gibbons has written about Buprenorphine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.549 |
|
|
|
-
Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare. J Subst Use Addict Treat. 2024 02; 157:209271.
Score: 0.715
-
Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder. JAMA Psychiatry. 2022 12 01; 79(12):1173-1179.
Score: 0.665
-
Solomon KT, O'Connor J, Gibbons JB, Kilaru AS, Feder KA, Xue L, Saloner B, Stuart EA, Cole ES, Hulsey E, Meisel Z, Patel E, Donohue JM. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge. JAMA Health Forum. 2023 03 03; 4(3):e230245.
Score: 0.169
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|